EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Exploring Ferroptosis in Allergic Inflammatory Diseases: Emerging Mechanisms and Therapeutic Perspectives

Henry Sutanto, Laras Pratiwi, Deasy Fetarayani iD

Cell Biology International · 2025

DOI: 10.1002/cbin.70026 ↗

At a glance

Übersichtsarbeit in Cell Biology International, 2025. Written by Henry Sutanto and 2 co-authors. Institution: Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Major MEDLINE topics: Ferroptosis, Inflammation, Hypersensitivity. Cited 7 times so far (Crossref); 99 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Ferroptosis, a unique form of regulated cell death driven by iron accumulation and lipid peroxidation, has emerged as a critical process in various diseases. Recent evidence suggests its involvement in the pathogenesis of allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis. These conditions are characterized by chronic inflammation, oxidative stress, and immune dysregulation, all of which intersect with the molecular mechanisms of ferroptosis. Key regulators, such as glutathione peroxidase 4 (GPX4), the cystine/glutamate antiporter system Xc‐, and iron metabolism pathways, play pivotal roles in ferroptotic processes and their contribution to allergic disease progression. This review explores the mechanistic link between ferroptosis and allergic diseases, emphasizing how oxidative damage and iron overload exacerbate inflammation and tissue injury. We also highlight emerging diagnostic biomarkers, including lipid peroxidation products and iron regulators, which could improve disease monitoring and stratification. Therapeutic strategies targeting ferroptosis, such as GPX4 activators, iron chelators, and lipid peroxidation inhibitors, show promise in preclinical\ studies, offering potential new avenues for treating allergic diseases. However, challenges remain in translating these findings into clinical applications. By integrating current knowledge, this review underscores the need for further research into ferroptosis as both a biomarker and therapeutic target in allergic diseases.

Subjects

MeSH terms (MEDLINE)

FerroptosisInflammationHypersensitivityHumansLipid PeroxidationAnimalsIronBiomarkersOxidative StressPhospholipid Hydroperoxide Glutathione Peroxidase

Author keywords

allergycell biologycell deathferroptosisimmunology

Substances

IronBiomarkersPhospholipid Hydroperoxide Glutathione Peroxidase

Authors and institutions

  • Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
  • Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

ORCID profiles: Deasy Fetarayani

Cite

APA

Sutanto, H., Pratiwi, L., & Fetarayani, D. (2025). Exploring Ferroptosis in Allergic Inflammatory Diseases: Emerging Mechanisms and Therapeutic Perspectives. Cell Biology International. https://doi.org/10.1002/cbin.70026

Vancouver

Sutanto H, Pratiwi L, Fetarayani D. Exploring Ferroptosis in Allergic Inflammatory Diseases: Emerging Mechanisms and Therapeutic Perspectives. Cell Biology International. 2025. doi:10.1002/cbin.70026

BibTeX
@article{Sutanto2025,
  author = {Sutanto, Henry and Pratiwi, Laras and Fetarayani, Deasy},
  title = {Exploring Ferroptosis in Allergic Inflammatory Diseases: Emerging Mechanisms and Therapeutic Perspectives},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.70026}
}
Start for free →